Skip to content

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05292534
Enrollment
38
Registered
2022-03-23
Start date
2022-06-01
Completion date
2023-09-20
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Sensorineural, Tinnitus

Brief summary

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

Detailed description

2 groups of adults with hearing loss and chronic bothersome tinnitus and no experience with amplification will participate in a cross over intervention study with 2 conditions of 4 weeks each: 1. fit with hearing aid (HA) amplification-only, and 2. fit with HA amplification with an added sound, returning to their original unaided condition after undergoing the intervention phase.

Interventions

DEVICEhearing aid amplification

Hearing aid will be fit to prescribed participant hearing loss.

DEVICEhearing aid amplification with an added sound

Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated.

Sponsors

State University of New York at Buffalo
CollaboratorOTHER
Sonova AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hearing loss * candidate for hearing aid amplification * Bothersome chronic tinnitus (3 months+)

Exclusion criteria

* age less than 18 years * normal hearing * tinnitus presence for less than 3 months * tinnitus not bothersome enough to warrant intervention * non hearing aid candidates

Design outcomes

Primary

MeasureTime frameDescription
Tinnitus Functional Index Evaluation (TFI)TFI collected before intervention to serve as a baseline. TFI change from baseline will be assessed after each study condition, which will last 4 weeks/each.Tinnitus Functional Index (TFI) questionnaire results, ranging from 0 to 100, with higher numbers indicating more severe (worse) Tinnitus interference in the person's quality of life.

Countries

United States

Participant flow

Recruitment details

38 participants signed the consent form and met study criteria

Pre-assignment details

38 participants were randomly assigned into one of two groups. Out of the 38 participants, 8 dropped out during the study. There were 2 study groups in this cross-over study, and final numbers were 15 participants in each group.

Participants by arm

ArmCount
Cross Over Design, 2 Groups of Participants
First Group: started with amplification-only as a 1st intervention, and switched to amplification+noiser Second Group: started with amplification+noiser as a 1st intervention, and switched to amplification-only
30
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation34
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicCross Over Design, 2 Groups of Participants
Age, Continuous
Group 1
62.2 years
STANDARD_DEVIATION 9.5
Age, Continuous
Group 2
60.6 years
STANDARD_DEVIATION 9.1
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
30 Participants
Sex: Female, Male
Group 1
Female
8 Participants
Sex: Female, Male
Group 1
Male
7 Participants
Sex: Female, Male
Group 2
Female
4 Participants
Sex: Female, Male
Group 2
Male
11 Participants
TFI
Group 1
50 points
STANDARD_DEVIATION 16.1
TFI
Group 2
36.2 points
STANDARD_DEVIATION 19

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 300 / 30
other
Total, other adverse events
2 / 301 / 302 / 30
serious
Total, serious adverse events
0 / 300 / 300 / 30

Outcome results

Primary

Tinnitus Functional Index Evaluation (TFI)

Tinnitus Functional Index (TFI) questionnaire results, ranging from 0 to 100, with higher numbers indicating more severe (worse) Tinnitus interference in the person's quality of life.

Time frame: TFI collected before intervention to serve as a baseline. TFI change from baseline will be assessed after each study condition, which will last 4 weeks/each.

Population: Repeated measures. Participants served as their own control.

ArmMeasureGroupValue (MEAN)Dispersion
Amplification-onlyTinnitus Functional Index Evaluation (TFI)Group 135.6 units on a scaleStandard Deviation 20
Amplification-onlyTinnitus Functional Index Evaluation (TFI)Group 236.2 units on a scaleStandard Deviation 19
Amplification With Added SoundTinnitus Functional Index Evaluation (TFI)Group 132 units on a scaleStandard Deviation 21.9
Amplification With Added SoundTinnitus Functional Index Evaluation (TFI)Group 234.4 units on a scaleStandard Deviation 19.7
No InterventionTinnitus Functional Index Evaluation (TFI)Group 144.8 units on a scaleStandard Deviation 22.2
No InterventionTinnitus Functional Index Evaluation (TFI)Group 240.4 units on a scaleStandard Deviation 16.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026